Crispr Therapeutics shares owned by R.H. Bluestein & Company
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by R.H. Bluestein & Company
from 13F filings
Historical chart of R.H. Bluestein & Company investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by R.H. Bluestein & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by R.H. Bluestein & Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2022-09-30 | $372k | 5.7k | 65.26 |
| 2022-06-30 | $356k | 5.9k | 60.85 |
| 2022-03-31 | $368k | 5.9k | 62.80 |
| 2021-12-31 | $476k | 6.3k | 75.86 |
| 2021-09-30 | $814k | 7.3k | 111.89 |
| 2021-06-30 | $1.9M | 12k | 161.91 |
| 2021-03-31 | $908k | 7.5k | 121.88 |
| 2020-12-31 | $1.0M | 6.6k | 153.13 |
| 2020-09-30 | $477k | 5.7k | 83.68 |
| 2020-06-30 | $441k | 6.0k | 73.50 |
| 2020-03-31 | $3.5M | 82k | 42.40 |
| 2019-12-31 | $640k | 11k | 60.95 |
| 2019-09-30 | $291k | 7.1k | 40.99 |
| 2019-06-30 | $353k | 7.5k | 47.07 |